Безопасен ли 4-butylresorcinol при беременности?

Pregnancy-safe products containing 4-butylresorcinol

Safi

Safi Perfect White Hydrating Lotion

99/100

roromendut

roromendut Roro Mendut Bright & Lift Eye Cream

98/100

Noreva

Noreva Iklen+ Perfect Sublim Serum Anti Dark Spot Corrector Serum

98/100

Eucerin

Eucerin Itch Relief Intensive Calming Lotion

98/100

STANDARD SEOUL Barrier Glass Gel Cream - 50ml

98/100

By Ecom

By Ecom Spot Eraser Vita Cream

97/100

Dr Idris

Dr Idris Major Fade Active Seal Moisturizer

97/100

Glow Lab

Glow Lab Gentle Bright Serum

97/100

By Ecom

By Ecom Spot Eraser Ampoule

97/100

Ivatherm

Ivatherm Ivawhite Intensive Whitening Serum

97/100

Related ingredients

См. также

• Безопасен ли 4-butylresorcinol для малышей?

Frequently asked questions

Безопасен ли 4-butylresorcinol при беременности?

No harmonised CLP reproductive classification or SCCS/CIR reproductive advisory was found for 4‑butylresorcinol (ECHA substance page and registration dossiers). Peer‑reviewed literature on this substance deals with topical depigmentation/tyrosinase inhibition and formulation/irritation, not developmental/reproductive toxicity, so there is no evidence to justify a reproductive hazard score. Topical use can result in low but measurable exposure in adults (see formulation/penetration studies). ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))

Безопасен ли 4-butylresorcinol при грудном вскармливании?

As for pregnancy: no evidence or regulatory classification indicating reproductive or lactation-specific hazard was found. Topical use implies low but measurable systemic exposure in adults; therefore breastfeeding exposure is considered low/measurable but no data show transfer in milk or nursing‑infant effects. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.126.948?utm_source=openai))

Безопасен ли 4-butylresorcinol для кожи малыша?

No infant‑specific hazard or mechanistic data were identified. Per the scoring rules, because 4‑butylresorcinol has measurable dermal availability in topical formulations for adults, baby exposure is increased by +1 (immature barrier, higher surface‑area:weight), so exposure is rated moderate. No studies demonstrating infant-specific toxicity were found. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/39326268/?utm_source=openai))

Как VeriMom оценивает 4-butylresorcinol?

VeriMom оценивает 4-butylresorcinol в 93/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы 4-butylresorcinol при беременности?

См. наш список безопасных альтернатив 4-butylresorcinol с аналогичной функцией и классификацией без известных рисков.